This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Han Sheng Phamtech, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Inventor Kun-Yi Hong: Innovating Diabetic Retinopathy Treatments
Introduction
Kun-Yi Hong, based in Pingtung County, Taiwan, is a notable inventor recognized for his contributions to healthcare, specifically in treating diabetic retinopathy. With a focus on herbal compositions, his innovative methods aim to alleviate symptoms associated with this serious condition.
Latest Patents
Kun-Yi Hong holds one significant patent titled "Method for treating diabetic retinopathy." This patent involves a herbal composition designed to relieve symptoms of diabetic retinopathy, which includes 40 weight percent of an ethanol extract, 8 weight percent of another ethanol extract, and 52 weight percent of a water extract. The method outlined in the patent describes how this herbal formulation can be administered to individuals in need, showcasing a natural approach to managing this eye disease.
Career Highlights
Kun-Yi is associated with Han Sheng Pharmtech, Inc., a company that focuses on pharmaceutical innovations. Throughout his career, he has committed himself to advancing medical treatments and exploring alternative therapies through research and development.
Collaborations
Within his professional environment, Kun-Yi collaborates with esteemed colleagues, including Shorong-Shii Liou and I-Min Liu. These collaborations foster a rich exchange of ideas and research endeavors that contribute to the advancement of healthcare solutions.
Conclusion
Kun-Yi Hong’s work represents a significant step forward in the treatment of diabetic retinopathy, bridging the gap between traditional herbal medicine and modern therapeutic practices. With continued research and collaboration, his innovative approaches may pave the way for new treatment options that improve the quality of life for individuals affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile